Three new screenings will soon be added to Louisiana’s newborn screenings. Signed by Governor Edwards in June, the bill, presented by Representative Paula Davis, adds mucopolysaccharidosis type I (MPS I), glycogen storage disorder type II, and Krabbe disease to the state’s newborn screening panel. MPS I is a progressively debilitating disorder caused by mutations in the IDUA gene. Glycogen storage disorder type II, or Pompe disease, is an inherited metabolic disorder, and Krabbe disease is an inherited disorder that destroys the protective coating of nerve cells in the brain and throughout the nervous system.The new screenings will begin January 1, 2022.
New Infant Screenings
